[Daiichi Sankyo Healthcare Co., Ltd.] Notice regarding sales of OTC drug “Mightia” brand
*View in browser* *Daiichi Sankyo Healthcare Co., Ltd.*
Press release: March 29, 2024
*To all members of the press*
Notice regarding sales of OTC drug “Mightia” brand
*Senju Pharmaceutical and Daiichi Sankyo Healthcare partner in sales -Renewal launch on Thursday, April 11, 2024-*
Senju Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Osaka, Representative Director: Shuhei Yoshida, hereinafter referred to as Senju Pharmaceutical) and Daiichi Sankyo Healthcare Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Representative Director and President: Katsuhiko Yoshida, hereinafter referred to as Daiichi Sankyo Healthcare Co., Ltd. Ichisankyo Healthcare) has decided to enter into a sales partnership for the OTC drug “Mightia” brand from April 1, 2024.
In line with this, all 19 products under the “Mightia” brand will be relaunched with a new package design. There are no changes to the prescription, efficacy, dosage, or manufacturer’s suggested retail price.
While considering the growth strategy for Mightia, Senju
Pharmaceutical decided to enter into a sales partnership with the company, believing that it would be possible to build a long-term and favorable partnership. Both companies will work together to further grow Mightia.
Daiichi Sankyo Healthcare has been developing products in the main field of OTC drugs, and with the addition of the “Mightia” brand, which has a rich lineup, Daiichi Sankyo Healthcare will greatly strengthen its field of eye drops. In the future, the two companies will promote their partnership to meet the increasing needs for maintaining and improving visual function due to lifestyle changes brought about by digitalization and the aging of the population. of life).
* ・Sales partnership start date*
Monday, April 1, 2024
*・Renewal product release date*
Thursday, April 11, 2024
* ·Products*
19 items in total *Please refer to the release text (PDF) for details
* ・About the over-the-counter (OTC) drug brand “Mightia” *
“Mightia” was launched in 1965 (Showa 40) as Japan’s first tear-type eye drop, focusing on tears, which are “God’s eye drops.” Currently, “Mightia” is being offered as Senju Pharmaceutical’s
over-the-counter (OTC) drug brand in response to the changing needs of the times.
“As a pioneer of tear-based eye drops, Mytear is committed to the importance of tears. Just like tears, Mytear will always be gentle to your eyes and heart, spreading smiles all over the world.”
Based on this belief, we would like to work to make the world brighter and more energetic by enhancing the power in everyone’s eyes and enabling them to communicate with positive feelings.
* ・About Senju Pharmaceutical*
For more than 70 years since its establishment in 1947, Senju Pharmaceutical has strived to provide original and superior medicines and services mainly in the field of ophthalmology, using unique ideas and R&D capabilities. We use the collective name of Senju
Pharmaceutical’s values that have been cultivated throughout our history as “SENJU”.
It’s called “SENSE”. The core of this is the “Big
We are not just a company, but a company that pursues happiness for all people involved with Senju Pharmaceutical.
Our management philosophy is to continue to be a “company,” and our behavioral philosophy is to always think and act from the other person’s perspective, “If I were you.”
Changes in the environment surrounding society and medicine are only accelerating. In these difficult times, we will continue to look forward, take on challenges, and change in order to remain a valuable company while unwaveringly upholding these values.
By permanently creating innovative medicines and services (*1), we will increase the quality of viewing (QOV) of patients around the world.
We hope to continue to be a company that is trusted and needed by society by contributing to the maintenance and improvement of our vision.
*1: Soutei (coined word) To create, propose, and provide.
* ・About Daiichi Sankyo Healthcare*
Based on the Daiichi Sankyo Group’s (*2) corporate philosophy of “providing pharmaceuticals that meet diverse medical needs,” Daiichi Sankyo Healthcare offers over-the-counter (OTC) medicines that consumers can select and purchase themselves. We are developing our business.
Currently, we are expanding our business domain beyond OTC drugs to include functional skin care, oral care, and foods, and have adopted the corporate slogan “Fit for You.”
We are striving to become a partner in creating a healthy lifestyle. Through these businesses, we promote “self-care” where everyone protects and takes care of their own health, and contribute to the realization of a society where everyone can stay healthy and beautiful.
*2: The Daiichi Sankyo Group is engaged in the business of innovative drugs (new drugs), generic drugs, vaccines, and OTC drugs.
* -Release original text (PDF)-*
https://www.daiichisankyo-hc.co.jp/content/000134416.pdf
[image: download] d5551-111-9e111c3797bb736cbf9bcaf91a02bee4.pdf *About details about this release*
https://prtimes.jp/main/html/rd/p/000000111.000005551.html
*Download press release materials*
https://prtimes.jp/im/action.php?run=html&page=releaseimage&company_id=5551&release_id=111